{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:27:02Z","timestamp":1781897222265,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01702-0","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T08:47:19Z","timestamp":1740646039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Identification and characterization of variants in PSEN1, PSEN2, and APP genes in Chinese patients with early-onset Alzheimer's disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Haitian","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"1702_CR1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34:939\u201344.","journal-title":"Neurology"},{"key":"1702_CR2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0317167100013949","volume":"39","author":"L Wu","year":"2012","unstructured":"Wu L, Rosa-Neto P, Hsiung GY, et al. Early-onset familial Alzheimer\u2019s disease (EOFAD). Can J Neurol Sci. 2012;39:436\u201345.","journal-title":"Can J Neurol Sci"},{"key":"1702_CR3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jalz.2009.03.001","volume":"5","author":"A Alzheimer's","year":"2009","unstructured":"Alzheimer\u2019s A. 2009 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2009;5:234\u201370.","journal-title":"Alzheimers Dement"},{"key":"1702_CR4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C. Molecular genetics of early-onset Alzheimer\u2019s disease revisited. Alzheimers Dement. 2016;12:733\u201348.","journal-title":"Alzheimers Dement"},{"key":"1702_CR5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000366272","volume":"39","author":"Z Shi","year":"2015","unstructured":"Shi Z, Wang Y, Liu S, et al. Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations. Dement Geriatr Cogn Disord. 2015;39:32\u201340.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1702_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med. 2016;18:421\u201330.","journal-title":"Genet Med"},{"key":"1702_CR7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","volume":"18","author":"S Khan","year":"2020","unstructured":"Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease. Curr Neuropharmacol. 2020;18:1106\u201325.","journal-title":"Curr Neuropharmacol"},{"key":"1702_CR8","doi-asserted-by":"crossref","first-page":"215 e211","DOI":"10.1016\/j.neurobiolaging.2016.09.008","volume":"49","author":"IS Barber","year":"2017","unstructured":"Barber IS, Braae A, Clement N, et al. Mutation analysis of sporadic early-onset Alzheimer\u2019s disease using the NeuroX array. Neurobiol Aging. 2017;49:215 e211\u2013215 e218.","journal-title":"Neurobiol Aging"},{"key":"1702_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"1702_CR10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"1702_CR11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566\u201372.","journal-title":"Br J Psychiatry"},{"key":"1702_CR12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"1702_CR13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-4886(91)90075-N","volume":"112","author":"F Owen","year":"1991","unstructured":"Owen F, Poulter M, Collinge J, et al. Insertions in the prion protein gene in atypical dementias. Exp Neurol. 1991;112:240\u20132.","journal-title":"Exp Neurol"},{"key":"1702_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245\u201356.","journal-title":"Neuron"},{"key":"1702_CR15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1702_CR16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1399-0004.1998.tb02597.x","volume":"53","author":"L Morelli","year":"1998","unstructured":"Morelli L, Prat MI, Levy E, Mangone CA, Castano EM. Presenilin 1 Met146Leu variant due to an A \u2013> T transversion in an early-onset familial Alzheimer\u2019s disease pedigree from Argentina. Clin Genet. 1998;53:469\u201373.","journal-title":"Clin Genet"},{"key":"1702_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2004.04.030","volume":"364","author":"P Coleman","year":"2004","unstructured":"Coleman P, Kurlan R, Crook R, Werner J, Hardy J. A new presenilin Alzheimer\u2019s disease case confirms the helical alignment of pathogenic mutations in transmembrane domain 5. Neurosci Lett. 2004;364:139\u201340.","journal-title":"Neurosci Lett"},{"key":"1702_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpsychires.2019.03.026","volume":"113","author":"G Wang","year":"2019","unstructured":"Wang G, Zhang DF, Jiang HY, et al. Mutation and association analyses of dementia-causal genes in Han Chinese patients with early-onset and familial Alzheimer\u2019s disease. J Psychiatr Res. 2019;113:141\u20137.","journal-title":"J Psychiatr Res"},{"key":"1702_CR19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3233\/JAD-2012-120172","volume":"30","author":"D Wallon","year":"2012","unstructured":"Wallon D, Rousseau S, Rovelet-Lecrux A, et al. The French series of autosomal dominant early onset Alzheimer\u2019s disease cases: mutation spectrum and cerebrospinal fluid biomarkers. J Alzheimers Dis. 2012;30:847\u201356.","journal-title":"J Alzheimers Dis"},{"key":"1702_CR20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/alz.12005","volume":"16","author":"L Jia","year":"2020","unstructured":"Jia L, Fu Y, Shen L, et al. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer\u2019s disease. Alzheimers Dement. 2020;16:178\u201391.","journal-title":"Alzheimers Dement"},{"key":"1702_CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3233\/JAD-161188","volume":"57","author":"J Dong","year":"2017","unstructured":"Dong J, Qin W, Wei C, Tang Y, Wang Q, Jia J. A novel PSEN1 K311R mutation discovered in Chinese families with late-onset Alzheimer\u2019s disease affects amyloid-beta production and tau phosphorylation. J Alzheimers Dis. 2017;57:613\u201323.","journal-title":"J Alzheimers Dis"},{"key":"1702_CR22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2174\/1567205020666221028112915","volume":"19","author":"C Liu","year":"2022","unstructured":"Liu C, Cong L, Zhu M, et al. Screening for genetic mutations associated with early-onset Alzheimer\u2019s disease in Han Chinese. Curr Alzheimer Res. 2022;19:724\u201333.","journal-title":"Curr Alzheimer Res"},{"key":"1702_CR23","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1038\/s41380-018-0224-0","volume":"25","author":"C Koriath","year":"2020","unstructured":"Koriath C, Kenny J, Adamson G, et al. Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series. Mol Psychiatry. 2020;25:3399\u2013412.","journal-title":"Mol Psychiatry"},{"key":"1702_CR24","first-page":"E476","volume":"114","author":"L Sun","year":"2017","unstructured":"Sun L, Zhou R, Yang G, Shi Y. Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Abeta42 and Abeta40 peptides by gamma-secretase. Proc Natl Acad Sci U S A. 2017;114:E476\u201385.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1702_CR25","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2147\/CIA.S116724","volume":"11","author":"SS An","year":"2016","unstructured":"An SS, Park SA, Bagyinszky E, et al. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer\u2019s disease. Clin Interv Aging. 2016;11:1817\u201322.","journal-title":"Clin Interv Aging"},{"key":"1702_CR26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3233\/JAD-220194","volume":"87","author":"L Dong","year":"2022","unstructured":"Dong L, Liu C, Sha L, et al. PSEN2 mutation spectrum and novel functionally validated mutations in Alzheimer\u2019s disease: data from PUMCH dementia cohort. J Alzheimers Dis. 2022;87:1549\u201356.","journal-title":"J Alzheimers Dis"},{"key":"1702_CR27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/ejhg.2015.173","volume":"24","author":"G Nicolas","year":"2016","unstructured":"Nicolas G, Wallon D, Charbonnier C, et al. Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons. Eur J Hum Genet. 2016;24:710\u20136.","journal-title":"Eur J Hum Genet"},{"key":"1702_CR28","doi-asserted-by":"crossref","first-page":"215 e215","DOI":"10.1016\/j.neurobiolaging.2018.11.024","volume":"76","author":"B Jiang","year":"2019","unstructured":"Jiang B, Zhou J, Li HL, et al. Mutation screening in Chinese patients with familial Alzheimer\u2019s disease by whole-exome sequencing. Neurobiol Aging. 2019;76:215 e215\u2013215 e221.","journal-title":"Neurobiol Aging"},{"key":"1702_CR29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WAD.0000000000000438","volume":"35","author":"XY Li","year":"2021","unstructured":"Li XY, Cui Y, Jing D, et al. Novel PSEN1 and PSEN2 mutations identified in sporadic early-onset Alzheimer disease and posterior cortical atrophy. Alzheimer Dis Assoc Disord. 2021;35:208\u201313.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1702_CR30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2019.05.185","volume":"516","author":"L Shen","year":"2019","unstructured":"Shen L, Qin W, Wu L, et al. Two novel presenilin-1 mutations (I249L and P433S) in early onset Chinese Alzheimer\u2019s pedigrees and their functional characterization. Biochem Biophys Res Commun. 2019;516:264\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1702_CR31","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1239725","volume":"14","author":"AC Mahungu","year":"2023","unstructured":"Mahungu AC, Steyn E, Floudiotis N, et al. The mutational profile in a South African cohort with inherited neuropathies and spastic paraplegia. Front Neurol. 2023;14: 1239725.","journal-title":"Front Neurol"},{"key":"1702_CR32","volume":"120","author":"H Li","year":"2022","unstructured":"Li H, Li Y, Liang W, et al. The identification of PSEN1 p.Tyr159Ser mutation in a non-canonic early-onset Alzheimer\u2019s disease family. Mol Cell Neurosci. 2022;120: 103715.","journal-title":"Mol Cell Neurosci"},{"key":"1702_CR33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3233\/JAD-181108","volume":"68","author":"J Liu","year":"2019","unstructured":"Liu J, Wang Q, Jing D, et al. Diagnostic approach of early-onset dementia with negative family history: implications from two cases of early-onset Alzheimer\u2019s disease with de novo PSEN1 mutation. J Alzheimers Dis. 2019;68:551\u20138.","journal-title":"J Alzheimers Dis"},{"key":"1702_CR34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41525-021-00235-3","volume":"6","author":"B Jiao","year":"2021","unstructured":"Jiao B, Liu H, Guo L, et al. The role of genetics in neurodegenerative dementia: a large cohort study in South China. NPJ Genom Med. 2021;6:69.","journal-title":"NPJ Genom Med"},{"key":"1702_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/1567205018666210608120339","volume":"18","author":"C Mao","year":"2021","unstructured":"Mao C, Li J, Dong L, et al. Clinical phenotype and mutation spectrum of Alzheimer\u2019s disease with causative genetic mutation in a Chinese cohort. Curr Alzheimer Res. 2021;18:265\u201372.","journal-title":"Curr Alzheimer Res"},{"key":"1702_CR36","doi-asserted-by":"crossref","first-page":"208 e211","DOI":"10.1016\/j.neurobiolaging.2015.09.016","volume":"37","author":"C Blauwendraat","year":"2016","unstructured":"Blauwendraat C, Wilke C, Jansen IE, et al. Pilot whole-exome sequencing of a German early-onset Alzheimer\u2019s disease cohort reveals a substantial frequency of PSEN2 variants. Neurobiol Aging. 2016;37:208 e211\u2013208 e217.","journal-title":"Neurobiol Aging"},{"key":"1702_CR37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/07853890802186905","volume":"40","author":"N Brouwers","year":"2008","unstructured":"Brouwers N, Sleegers K, Van Broeckhoven C. Molecular genetics of Alzheimer\u2019s disease: an update. Ann Med. 2008;40:562\u201383.","journal-title":"Ann Med"},{"key":"1702_CR38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","volume":"65","author":"D Campion","year":"1999","unstructured":"Campion D, Dumanchin C, Hannequin D, et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999;65:664\u201370.","journal-title":"Am J Hum Genet"},{"key":"1702_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/hmg\/7.1.43","volume":"7","author":"M Cruts","year":"1998","unstructured":"Cruts M, van Duijn CM, Backhovens H, et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet. 1998;7:43\u201351.","journal-title":"Hum Mol Genet"},{"key":"1702_CR40","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1007\/s10072-022-06168-8","volume":"43","author":"D Csaban","year":"2022","unstructured":"Csaban D, Illes A, Renata TB, et al. Genetic landscape of early-onset dementia in Hungary. Neurol Sci. 2022;43:5289\u2013300.","journal-title":"Neurol Sci"},{"issue":"1481","key":"1702_CR41","first-page":"e1487","volume":"33","author":"V Dobricic","year":"2012","unstructured":"Dobricic V, Stefanova E, Jankovic M, et al. Genetic testing in familial and young-onset Alzheimer\u2019s disease: mutation spectrum in a Serbian cohort. Neurobiol Aging. 2012;33(1481):e1487\u2013e1412.","journal-title":"Neurobiol Aging"},{"key":"1702_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"HM Lanoiselee","year":"2017","unstructured":"Lanoiselee HM, Nicolas G, Wallon D, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017;14: e1002270.","journal-title":"PLoS Med"},{"key":"1702_CR43","first-page":"201 e209","volume":"86","author":"TH Wong","year":"2020","unstructured":"Wong TH, Seelaar H, Melhem S, Rozemuller AJM, van Swieten JC. Genetic screening in early-onset Alzheimer\u2019s disease identified three novel presenilin mutations. Neurobiol Aging. 2020;86:201 e209\u2013201 e214.","journal-title":"Neurobiol Aging"},{"key":"1702_CR44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0014-4886(03)00384-4","volume":"184","author":"C Zekanowski","year":"2003","unstructured":"Zekanowski C, Styczynska M, Peplonska B, et al. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer\u2019s disease in Poland. Exp Neurol. 2003;184:991\u20136.","journal-title":"Exp Neurol"},{"key":"1702_CR45","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101082","volume":"26","author":"G Nicolas","year":"2024","unstructured":"Nicolas G, Zarea A, Lacour M, et al. Assessment of Mendelian and risk-factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening. Genet Med. 2024;26: 101082.","journal-title":"Genet Med"},{"key":"1702_CR46","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.3390\/ijms20194757","volume":"20","author":"VV Giau","year":"2019","unstructured":"Giau VV, Bagyinszky E, Youn YC, An SSA, Kim S. APP, PSEN1, and PSEN2 mutations in Asian patients with early-onset Alzheimer disease. Int J Mol Sci. 2019;20:4757.","journal-title":"Int J Mol Sci"},{"key":"1702_CR47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000350872","volume":"36","author":"Y Ji","year":"2013","unstructured":"Ji Y, Liu M, Huo YR, et al. Apolipoprotein Epsilon epsilon4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2013;36:163\u201370.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1702_CR48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004704","volume":"10","author":"J Couthouis","year":"2014","unstructured":"Couthouis J, Raphael AR, Daneshjou R, Gitler AD. Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis. PLoS Genet. 2014;10: e1004704.","journal-title":"PLoS Genet"},{"key":"1702_CR49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.WNL.0000042088.22694.E3","volume":"60","author":"JC Janssen","year":"2003","unstructured":"Janssen JC, Beck JA, Campbell TA, et al. Early onset familial Alzheimer\u2019s disease: mutation frequency in 31 families. Neurology. 2003;60:235\u20139.","journal-title":"Neurology"},{"key":"1702_CR50","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.60.11.1541","volume":"60","author":"A Tedde","year":"2003","unstructured":"Tedde A, Nacmias B, Ciantelli M, et al. Identification of new presenilin gene mutations in early-onset familial Alzheimer disease. Arch Neurol. 2003;60:1541\u20134.","journal-title":"Arch Neurol"},{"key":"1702_CR51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10048-002-0136-6","volume":"4","author":"AM Bertoli Avella","year":"2002","unstructured":"Bertoli Avella AM, Marcheco Teruel B, Llibre Rodriguez JJ, et al. A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease. Neurogenetics. 2002;4:97\u2013104.","journal-title":"Neurogenetics"},{"key":"1702_CR52","first-page":"256","volume":"18","author":"HH Klunemann","year":"2004","unstructured":"Klunemann HH, Rogaeva E, Neumann M, et al. Novel PS1 mutation in a Bavarian kindred with familial Alzheimer disease. Alzheimer Dis Assoc Disord. 2004;18:256\u20138.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1702_CR53","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1042\/BST20130201","volume":"41","author":"M McBrayer","year":"2013","unstructured":"McBrayer M, Nixon RA. Lysosome and calcium dysregulation in Alzheimer\u2019s disease: partners in crime. Biochem Soc Trans. 2013;41:1495\u2013502.","journal-title":"Biochem Soc Trans"},{"key":"1702_CR54","doi-asserted-by":"crossref","unstructured":"Gan J, Zhou H, Liu C, Fang L. PSEN2 and ABCA7 variants causing early-onset preclinical pathological changes in Alzheimer's disease: a case report and literature review. Neurol Sci. 2023;44(6):1987\u20132001.","DOI":"10.1007\/s10072-023-06602-5"},{"key":"1702_CR55","doi-asserted-by":"crossref","first-page":"696","DOI":"10.14336\/AD.2018.0208","volume":"9","author":"Y Xu","year":"2018","unstructured":"Xu Y, Liu X, Shen J, et al. The whole exome sequencing clarifies the genotype- phenotype correlations in patients with early-onset dementia. Aging Dis. 2018;9:696\u2013705.","journal-title":"Aging Dis"},{"key":"1702_CR56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-2377-14-105","volume":"14","author":"YC Youn","year":"2014","unstructured":"Youn YC, Bagyinszky E, Kim H, Choi BO, An SS, Kim S. Probable novel PSEN2 Val214Leu mutation in Alzheimer\u2019s disease supported by structural prediction. BMC Neurol. 2014;14:105.","journal-title":"BMC Neurol"},{"key":"1702_CR57","doi-asserted-by":"crossref","unstructured":"Liu L, Schultz SA, Saba A, et al. The pathogenicity of PSEN2 variants is tied to Abeta production and homology to PSEN1. Alzheimers Dement. 2024;20(12):8867\u201377.","DOI":"10.1002\/alz.14339"},{"key":"1702_CR58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-2006-9S344","volume":"9","author":"C Van Broeckhoven","year":"2006","unstructured":"Van Broeckhoven C, Kumar-Singh S. Genetics and pathology of alpha-secretase site AbetaPP mutations in the understanding of Alzheimer\u2019s disease. J Alzheimers Dis. 2006;9:389\u201398.","journal-title":"J Alzheimers Dis"},{"key":"1702_CR59","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhang CM, Prokopenko D, et al. An APP ectodomain mutation outside of the Abeta domain promotes Abeta production in vitro and deposition in vivo. J Exp Med. 2021;218(6):e20210313.","DOI":"10.1084\/jem.20210313"},{"key":"1702_CR60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnmol.2017.00022","volume":"10","author":"D Hefter","year":"2017","unstructured":"Hefter D, Draguhn A. APP as a protective factor in acute neuronal insults. Front Mol Neurosci. 2017;10:22.","journal-title":"Front Mol Neurosci"},{"issue":"Suppl 1","key":"1702_CR61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","volume":"120","author":"S Chasseigneaux","year":"2012","unstructured":"Chasseigneaux S, Allinquant B. Functions of Abeta, sAPPalpha and sAPPbeta\u202f: similarities and differences. J Neurochem. 2012;120(Suppl 1):99\u2013108.","journal-title":"J Neurochem"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01702-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T08:47:33Z","timestamp":1740646053000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01702-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1702"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01702-0","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committees of the Xuanwu Hospital of Capital Medical University (approval number: 2020026), and it was carried out in compliance with the Declaration of Helsinki\u2019s principles. Written informed consent was obtained from each patient or their guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the guardian of each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}